http://ift.tt/1sHX1gh
Pharmaceutical and biotechnology-derived products have been garnering the greatest public and professional attention in treating victims of Ebola virus disease. But a small company leveraging a clinically-tested treatment for shock and multi-organ failure may be the dark horse victor in the race to stop the West African outbreak.
from Forbes Real Time http://onforb.es/1GYUm3Z
Pharmaceutical and biotechnology-derived products have been garnering the greatest public and professional attention in treating victims of Ebola virus disease. But a small company leveraging a clinically-tested treatment for shock and multi-organ failure may be the dark horse victor in the race to stop the West African outbreak.
from Forbes Real Time http://onforb.es/1GYUm3Z
